Handling Missing Data in Clinical Trials: An Overview

被引:0
|
作者
William R. Myers
机构
[1] Procter and Gamble Pharmaceuticals,Department of Biometrics and Statistical Sciences
[2] Procter and Gamble Pharmaceuticals,Department of Biometrics and Statistical Sciences
关键词
Clinical trials; Missing data; Dropouts; Imputation methods; Missing-data mechanism;
D O I
暂无
中图分类号
学科分类号
摘要
A major problem in the analysis of clinical trials is missing data caused by patients dropping out of the study before completion. This problem can result in biased treatment comparisons and also impact the overall statistical power of the study. This paper discusses some basic issues about missing data as well as potential “watch outs.” The topic of missing data is often not a major concern until it is time for data collection and data analysis. This paper provides potential design considerations that should be considered in order to mitigate patients from dropping out of a clinical study. In addition, the concept of the missing-data mechanism is discussed. Five general strategies of handling missing data are presented: I. Complete-case analysis, 2. “Weighting methods,” 3. Imputation methods, 4. Analyzing data as incomplete, and 5. “Other” methods. Within each strategy, several methods are presented along with advantages and disadvantages. Also briefly discussed is how the International Conference on Harmonization (ICH) addresses the issue of missing data. Finally, several of the methods that are illustrated in the paper are compared using a simulated data set.
引用
收藏
页码:525 / 533
页数:8
相关论文
共 50 条
  • [1] Handling missing data in clinical trials: An overview
    Myers, WR
    DRUG INFORMATION JOURNAL, 2000, 34 (02): : 525 - 533
  • [2] AN OVERVIEW OF PRACTICAL APPROACHES FOR HANDLING MISSING DATA IN CLINICAL TRIALS
    DeSouza, Cynthia M.
    Legedza, Anna T. R.
    Sankoh, Abdul J.
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2009, 19 (06) : 1055 - 1073
  • [3] A review of the handling of missing longitudinal outcome data in clinical trials
    Matthew Powney
    Paula Williamson
    Jamie Kirkham
    Ruwanthi Kolamunnage-Dona
    Trials, 15
  • [4] Handling missing data issues in clinical trials for rheumatic diseases
    Wong, Weng Kee
    Boscardin, W. J.
    Postlethwaite, A. E.
    Furst, D. E.
    CONTEMPORARY CLINICAL TRIALS, 2011, 32 (01) : 1 - 9
  • [5] A review of the handling of missing longitudinal outcome data in clinical trials
    Powney, Matthew
    Williamson, Paula
    Kirkham, Jamie
    Kolamunnage-Dona, Ruwanthi
    TRIALS, 2014, 15
  • [6] Commentary: Indefensible Methods of Handling Missing Data in Clinical Trials
    Arndt, Stephan
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2013, 37 (12) : 1997 - 1998
  • [7] MISSING DATA HANDLING METHODS IN MEDICAL DEVICE CLINICAL TRIALS
    Yan, Xu
    Lee, Shiowjen
    Li, Ning
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2009, 19 (06) : 1085 - 1098
  • [8] Randomization tests in clinical trials with multiple imputation for handling missing data
    Ivanova, Anastasia
    Lederman, Seth
    Stark, Philip B.
    Sullivan, Gregory
    Vaughn, Ben
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2022, 32 (03) : 441 - 449
  • [9] Considerations of multiple imputation approaches for handling missing data in clinical trials
    Quan, Hui
    Qi, Li
    Luo, Xiaodong
    Darchy, Loic
    CONTEMPORARY CLINICAL TRIALS, 2018, 70 : 62 - 71
  • [10] MISSING RADIOGRAPHIC DATA HANDLING IN RANDOMIZED CLINICAL TRIALS IN RHEUMATOID ARTHRITIS
    Huang, Xiaohong
    Jiao, Lixia
    Wei, Lynn
    Quan, Hui
    Teoh, Leah
    Koch, Gary G.
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2013, 23 (06) : 1435 - 1452